diabetes

AstraZeneca: A Positive Future Awaits This Company
Seeking Alpha
Tue, 11/26/13 - 04:48 pm
AstraZeneca
Bristol-Myers Squibb
Xigduo
diabetes
Dapagliflozin
The FDA, The Avandia Diabetes Pill And Meta-Analyses
Pharmalot
Tue, 11/26/13 - 09:41 am
FDA
Avandia
GSK
diabetes
MannKind: A Breakout Biotechnology Bet
Seeking Alpha
Tue, 11/26/13 - 08:49 am
MannKind
Afrezza
diabetes
FDA overturns safety restrictions on diabetes pill Avandia based on new heart safety data
Yahoo/AP
Mon, 11/25/13 - 06:17 pm
FDA
Avandia
GSK
diabetes
Profit bonanza eludes companies chasing obesity business
Reuters
Fri, 11/15/13 - 09:42 am
obesity
diabetes
Novo Nordisk
Arena Pharmaceuticals
Vivus
Tandem Diabetes shares surge 30% above IPO price
Mass Device
Thu, 11/14/13 - 10:56 am
Tandem Diabetes
devices
diabetes
IPOs
Diabetes battle "being lost" as cases hit record 382 mln
Yahoo/Reuters
Thu, 11/14/13 - 10:36 am
diabetes
China
type 2 diabetes
Eli Lilly to invest $700M to enhance global insulin manufacturing capacity
Yahoo/Fly on the Wall
Thu, 11/14/13 - 10:29 am
Eli Lilly
drug manufacturing
insulin
diabetes
After Bristol-Myers R&D cuts, will AstraZeneca amp up its share of diabetes JV?
Fierce Pharma
Fri, 11/8/13 - 11:11 am
AstraZeneca
Bristol-Myers Squibb
diabetes
Novo Nordisk And The Danish Delusion
Forbes
Fri, 11/8/13 - 10:50 am
Novo Nordisk
Denmark
Eli Lilly
diabetes
insulin
This Diabetes Giant Could Face 3 Major Challenges
Motley Fool
Tue, 11/5/13 - 09:57 am
diabetes
Novo Nordisk
Tresiba
GLP-1 agonist
Victoza
Drug pricing challenges diabetes king Novo Nordisk
Reuters
Tue, 11/5/13 - 08:38 am
drug pricing
diabetes
Novo Nordisk
These 2 Businesses Could Boost Sanofi's Top Line
Motley Fool
Sun, 11/3/13 - 12:10 pm
Sanofi
diabetes
orphan drugs
New two-hormone Roche drug shows promise in diabetes, obesity
Reuters
Thu, 10/31/13 - 11:29 am
Roche
obesity
diabetes
GLP-1 agonist
MannKind announces FDA acknowledgement of NDA resubmission for Afrezza
Yahoo/Fly on the Wall
Wed, 10/30/13 - 09:45 am
diabetes
inhaled insulin
MannKind
FDA
Afrezza
Novo Nordisk Recalls FlexPen, Penfill Insulin in Europe
Bloomberg
Mon, 10/28/13 - 09:30 am
Novo Nordisk
recalls
Europe
insulin pen
insulin
diabetes
Penfill
FlexPen
Diabetes Giants Battle Outside of Their Usual Arena
Motley Fool
Thu, 10/24/13 - 11:29 am
Novo Nordisk
diabetes
Merck
Sanofi
NovoSeven
JNJ
Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
Yahoo
Mon, 10/21/13 - 05:51 pm
diabetes
Depomed
PDL Biopharma
Could This New Drug Application Lead to a Giant Leap for MannKind?
Motley Fool
Thu, 10/17/13 - 06:14 pm
MannKind
Afrezza
diabetes
Pfizer
MannKind asks for approval of Afrezza 2 years after FDA asked for more studies; shares rise
Yahoo/AP
Mon, 10/14/13 - 09:32 am
inhaled insulin
MannKind
diabetes
Afrezza
FDA

Pages